COVID-19 - Launch of production phase of EasyCov, a saliva-based screening test, with market entry in France and Europe set for June

The consortium formed by the biotechnology company SKILLCELL, a subsidiary of the ALCEN group, the CNRS SYS2DIAG laboratory (CNRS/ALCEN) and the digital company VOGO announces the production and marketing phases of the saliva test for the detection of SARS-COV-2 called EasyCov. There is already an efficient and reliable development, manufacture and distribution chain in place to prepare the swift deployment of the test.


This site uses cookies and analysis tools to improve the usability of the site. More information. |